Infection Disease & Health
- ISSN-L
- 2468-0451
- ISSN
- 2468-0869
- OpenAlex ID
- S2764661085
- APC list price
- $2,250
In 2025, Infection Disease & Health had an OJR of 0.47: its 2022–2024 papers received 47% of the world-average citations for comparable papers. Its Impact factor (2-year) was 1.43. Both figures are calculated from OpenAlex data.
Infection Disease & Health is Q3 in OpenJournalRank’s 2025 Infectious Diseases ranking (#179 of 258 eligible journals). These are OJR quartiles, calculated independently of SCImago, Scopus and JCR quartiles.
OpenAlex-listed APC: US$2,250 (source snapshot September 23, 2026). Check current charges with the journal.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method. For 2025 it counts non-self citations to the articles, reviews and conference papers a journal published in 2022–2024. Ranks and quartiles order journals by OJR within the subfield, the field and all journals.
0.47
Q3#179 of 258
The Impact factor (2-year) counts citations made in 2025 to the articles, reviews and conference papers a journal published in the two previous years (2023–2024), divided by the number of those papers. Self-citations count; citations from repository-hosted works do not. It is not normalized by field. Clarivate’s Journal Impact Factor™ uses the same basic formula but gives different numbers, and this site does not show it. Clarivate also counts citations to editorials, news and letters while dividing only by articles and reviews. OpenAlex sets document types automatically. The citing data differ: OpenAlex links references for most but not all works, and we leave out repository-hosted citing works. Publication years and snapshot dates also differ. Because of these differences, our value can be higher or lower than the JIF for a given journal, so don’t compare the two directly.
1.43
-19.3% change from 2024
from 1.77 in 2024
Why is it different?
- Journals usually quote Clarivate’s Journal Impact Factor™ (JIF).
- Same idea: citations this year to papers from the past two years, divided by those papers.
- The JIF also counts citations to editorials, news and letters but divides only by research papers. We count citations to research papers only.
- Different citation data (OpenAlex, not Web of Science) and timing.
So the two numbers can differ, in either direction, and the size of the difference has not been established. Compare ours with other journals here, not with the JIF.
Full explanation →OJR compares non-self citations to classified citable papers with the world-average expectation for their subfields, publication years and types.
Computed by OpenJournalRank from the OpenAlex snapshot of September 23, 2026; 472,521,793 citations counted across this release.
Looking for Clarivate’s Journal Impact Factor™? Check the Master Journal List
OJR rank in each category · 2025
The badge is the quartile; Q1 is the top quarter of ranked journals. Each track runs from the bottom of the category (left) to the top (right), shaded by quartile. The bold marker is this journal and the thin tick the category median. The outlined box is the likely rank range: the 95% interval from re-drawing the journal’s papers 1,000 times. “Spans Q1–Q2” means that range crosses a quartile boundary.
Ranking categories are derived from OpenAlex paper classifications and may differ from a journal’s stated scope.
At a glance
Quartile history in every category and the key figures for 2025, drawn as small charts.
Quartile by year
Each cell is the journal’s quartile among ranked journals in that category and year, by OJR. Q1 is the top quarter. Years run 2000–2025; tap or hover a cell for the exact rank.
2025Subfield · Infectious DiseasesQ3Rank 179 of 258#179 of 258
Each track runs from the bottom of the category (left) to the top (right), shaded by quartile. The bold marker is this journal, the outlined box its likely rank range and the thin tick the category median.
#179 of 258in Infectious Diseases
Citations made in 2025 to papers from 2023–2024, divided by the number of those papers, next to the same value a year earlier.
1.43-19.3%
Everything the journal published in 2025, split into articles, reviews and other items such as editorials. The line shows the last ten years.
181
Citations made in 2025 to papers from 2022–2024, divided by the number of those papers. Includes self-citations. The line shows the last ten years.
1.3
The median number of 2025 citations per paper from 2022–2024, next to the mean (cites per document). A mean far above the median means a few papers draw most of the citations.
1.0
Share of the journal’s 2022–2024 papers that are among the most cited 10% for their subfield, year and type. The marker at 10% is the world baseline.
2.8%
Share of 2025 citations to the journal’s 2022–2024 papers that come from the journal itself. The tick on the ring marks the field median.
10.4%
Share of documents published in 2025 that are free to read, across all document types.
19%
Share of documents published in 2025 with authors in two or more countries.
14%
All-time OpenAlex values at the snapshot date, not limited to the ranking window. The h-index is the largest h such that h papers have at least h citations each; the i10-index counts papers with at least 10 citations.
30h-index
Over the years
Impact factor (2-year)
Show the data as a table
| Year | Impact factor (2-year) |
|---|---|
| 2025 | 1.43 |
| 2024 | 1.77 |
| 2023 | 2.88 |
| 2022 | 3.76 |
| 2021 | 4.62 |
| 2020 | 2.76 |
| 2019 | 1.49 |
| 2018 | 0.83 |
| 2017 | 0.75 |
| 2016 | — |
OJR
Show the data as a table
| Year | OJR | Field median |
|---|---|---|
| 2025 | 0.47 | 0.67 |
| 2024 | 0.75 | 0.66 |
| 2023 | 0.77 | 0.66 |
| 2022 | 0.74 | 0.66 |
| 2021 | 0.74 | 0.66 |
| 2020 | 0.79 | 0.72 |
| 2019 | 0.48 | 0.70 |
| 2018 | 0.35 | 0.70 |
| 2017 | 0.19 | 0.72 |
| 2016 | — | 0.73 |
Trajectory against its field, 2022 → 2025
- OJR 2022 → 2025
- 0.74 → 0.47 -37%
- Median change in field
- -6%2,910 journals
- Relative to field
- -32%-54% to -1%
- Citable papers
- -15%127 → 108; field +6%
Show the data as a table
| Measure | Value |
|---|---|
| OJR 2022 → 2025 | 0.74 → 0.47 |
| Median change in field | -6% |
| Relative to field | -32% |
| Lower end of the bar | -54% |
| Upper end of the bar | -1% |
| Rising zone starts at | +10% |
| Falling zone starts at | -9.1% |
| Citable papers | 127 → 108 (-15%) |
Documents by type
Show the data as a table
| Year | Articles | Reviews | Other |
|---|---|---|---|
| 2025 | 180 | 0 | 1 |
| 2024 | 73 | 3 | 0 |
| 2023 | 65 | 3 | 0 |
| 2022 | 81 | 1 | 2 |
| 2021 | 71 | 0 | 1 |
| 2020 | 56 | 0 | 1 |
| 2019 | 72 | 2 | 1 |
| 2018 | 113 | 2 | 0 |
| 2017 | 122 | 1 | 0 |
| 2016 | 155 | 1 | 0 |
Citations to the previous three years
Show the data as a table
| Year | From other sources | Self-citations |
|---|---|---|
| 2025 | 129 | 15 |
| 2024 | 204 | 10 |
| 2023 | 350 | 6 |
| 2022 | 426 | 13 |
| 2021 | 505 | 26 |
| 2020 | 250 | 16 |
| 2019 | 110 | 26 |
| 2018 | 44 | 11 |
| 2017 | 8 | 10 |
| 2016 | 0 | 0 |
Share in the top 10% of their field
Show the data as a table
| Year | Top 10% share |
|---|---|
| 2025 | 2.8% |
| 2024 | 6.4% |
| 2023 | 11.8% |
| 2022 | 12.3% |
| 2021 | 10.2% |
| 2020 | 5.4% |
| 2019 | 4.1% |
| 2018 | 1.7% |
| 2017 | 2.5% |
| 2016 | — |
Collaboration and open access
Show the data as a table
| Year | International collaboration | Open access |
|---|---|---|
| 2025 | 13.8% | 18.8% |
| 2024 | 18.4% | 26.3% |
| 2023 | 7.4% | 58.8% |
| 2022 | 15.5% | 51.2% |
| 2021 | 12.5% | 73.6% |
| 2020 | 10.5% | 57.9% |
| 2019 | 9.3% | 21.3% |
| 2018 | 10.4% | 18.3% |
| 2017 | 11.4% | 19.5% |
| 2016 | 5.1% | 44.9% |
In context
How Infection Disease & Health compares with the journals of its comparison group: Medicine. Windows are 2022–2024 (retractions 2015–2024).
Each group is the journal’s field, or its domain when the field has too few eligible journals. On each value track the shaded band is the middle half of the group and the tick its median. The percentile under it is a mid-rank position out of 100: journals with a lower value count fully and tied journals count half, so ties share a mid-rank. Colour marks only retractions, cost and an unusual self-citation share; other differences carry no quality judgement.
- This journal
- Median
- Middle half of field
Integrity and cost
Retracted papers per 1,000
Papers marked retracted per 1,000 citable papers at the OpenAlex snapshot date; this does not show the reasons for retraction or assess a journal’s practices.
The comparison is the pooled rate across 3,472 field journals (all their retracted papers divided by all their papers), so there is no percentile.
0 retracted of 337 papers; field rate pooled across 3,472 journals
Listed APC (USD)
The article processing charge OpenAlex lists for the source; zero means a listed charge of $0.
Middle half of the field: $2,100–$3,920; median $3,046; n = 2,526 field journals.
Field percentile: 28/100 among 2,526 eligible journals
28/100Journal self-citation share
Share of citations to window papers that come from the same journal; a high share can reflect a narrow specialty and is not evidence of misconduct.
Middle half of the field: 1.3%–6.2%; median 3.2%; n = 3,512 field journals.
Field percentile: 90/100 among 3,512 eligible journals
90/100Openness and reach
Open access share
Share of window papers marked open access among papers with known OA status.
Middle half of the field: 43.5%–100.0%; median 100.0%; n = 4,521 field journals.
Field percentile: 35/100 among 4,521 eligible journals
35/100International collaboration share
Share of window papers with at least two distinct affiliation countries among papers with a known country.
Middle half of the field: 12.9%–28.9%; median 20.0%; n = 4,393 field journals.
Field percentile: 46/100 among 4,393 eligible journals
46/100Output growth
Change in citable paper counts between two adjacent three-year windows; it does not show changes in research quality or explain why output changed.
Middle half of the field: -23.4%–+18.4%; median -6.9%; n = 4,166 field journals.
Field percentile: 37/100 among 4,166 eligible journals
37/100Document mix
Review share
Reviews as a share of all citable window papers.
Middle half of the field: 0.8%–5.9%; median 2.8%; n = 4,521 field journals.
Field percentile: 73/100 among 4,521 eligible journals
73/100Articles-only OJR
OJR for classified window articles only, using the same baseline cells as the overall score.
Middle half of the field: 0.34–1.11; median 0.69; n = 4,492 field journals.
Field percentile: 32/100 among 4,492 eligible journals
32/100Citation distribution
Uncited share
Share of window papers receiving no non-self citations in the indicator year.
Middle half of the field: 24.2%–58.1%; median 37.6%; n = 4,521 field journals.
Field percentile: 61/100 among 4,521 eligible journals
61/100Citation concentration
Share of non-self citations received by the journal’s most-cited 10% of window papers.
Middle half of the field: 40.7%–55.6%; median 46.3%; n = 4,514 field journals.
Field percentile: 35/100 among 4,514 eligible journals
35/100Similar journals
Journals ranked nearest to this one in Infectious Diseases by OJR, 2025.
- #174Clinical Infection in PracticeQ3OJR 0.50
- #175Viral ImmunologyQ3OJR 0.49
- #176Journal of Global Infectious DiseasesQ3OJR 0.48
- #177International Journal of Translational MedicineQ3OJR 0.48
- #178Indian Journal of TuberculosisQ3OJR 0.48
- #179Infection Disease & Health (This journal)Q3OJR 0.47
- #180Clinical Microbiology NewsletterQ3OJR 0.47
- #181Japanese Journal of Infectious DiseasesQ3OJR 0.46
- #182International Journal of MycobacteriologyQ3OJR 0.46
- #183Human AntibodiesQ3OJR 0.45
- #184Iranian Journal of MicrobiologyQ3OJR 0.45
Detailed breakdown
The figures behind the charts, written out in full.
The two headline numbers
OJR is OpenJournalRank’s index, computed with the NCI3 method. It divides the non-self citations that papers published in 2022–2024 received in 2025 by the citations expected for papers of the same subfield, publication year and type worldwide. For 2022–2024, papers in this journal received 47% of the citations expected worldwide for comparable papers.
The Impact factor (2-year) is simpler: citations made in 2025 to the papers published in 2023 and 2024, divided by the number of those papers. For this journal it was 1.43, down from 1.77 in 2024 (-19.3%). It counts self-citations and is not adjusted for field, so a value of 5 means something different in economics and in molecular biology.
This value is computed from OpenAlex and is not Clarivate’s Journal Impact Factor™. The two use different citation sources and different rules for which items count, so the numbers will not match. Across all core journals, 84.3% of articles and reviews published in 2025 have at least one matched reference in OpenAlex (87.1% in 2024). This is a corpus-wide share: it does not measure how complete any one journal’s reference lists are, and no value on this page is adjusted for it.
Trajectory
Falling behind its field
OJR changed from 0.74 in 2022 to 0.47 in 2025 (-37%). Across 2,910 Medicine journals, the median change was -6%, so relative to its field this journal changed -32% (between -54% and -1% at two standard errors).
It published 127 citable papers in 2019–2021 and 108 in 2022–2024 (-15%). Across all journals, the number of Medicine papers changed +6% over the same periods. This counts articles, reviews and conference papers with a subfield in this field, including core and non-core journals.
A rising label needs a relative increase of at least 10%; a falling label needs a relative decrease of at least 9.1% (rounded). Both require at least 2 standard errors. Here the difference is 2.0 standard errors.
In context, in full
Descriptive comparisons with eligible journals ranked in 2025.
| Measure | This journal | Field or domain | Position |
|---|---|---|---|
| Journal self-citation shareShare of citations to window papers that come from the same journal; a high share can reflect a narrow specialty and is not evidence of misconduct. | 10.4%15 self-citations of 144 citations | Field median: 3.2%Medicine | percentile 90/100 among 3,512 eligible Medicine journals90/100 |
| Retracted papers per 1,000Papers marked retracted per 1,000 citable papers at the OpenAlex snapshot date; this does not show the reasons for retraction or assess a journal’s practices. | No retracted papers among 337 (field: 1.465 per 1,000) | Field pooled rate: 1.465 per 1,000Medicine | No percentile comparison |
| Output growthChange in citable paper counts between two adjacent three-year windows; it does not show changes in research quality or explain why output changed. | -15.0%108 papers in the later window; 127 in the earlier window | Field median: -6.9%Medicine | percentile 37/100 among 4,166 eligible Medicine journals37/100 |
| Open access shareShare of window papers marked open access among papers with known OA status. | 60.2%65 of 108 papers with known metadata | Field median: 100.0%Medicine | percentile 35/100 among 4,521 eligible Medicine journals35/100 |
| Listed APC (USD)The article processing charge OpenAlex lists for the source; zero means a listed charge of $0. | $2,250 | Field median: $3,046Medicine | percentile 28/100 among 2,526 eligible Medicine journals28/100 |
| International collaboration shareShare of window papers with at least two distinct affiliation countries among papers with a known country. | 18.9%20 of 106 papers with known metadata | Field median: 20.0%Medicine | percentile 46/100 among 4,393 eligible Medicine journals46/100 |
| Review shareReviews as a share of all citable window papers. | 5.6%6 reviews among 108 window papers | Field median: 2.8%Medicine | percentile 73/100 among 4,521 eligible Medicine journals73/100 |
| Articles-only OJRNormalized citation impact of classified window articles, using the same baseline cells as the overall OJR. | 0.42102 classified articles; all papers: 0.47 | Field median: 0.69Medicine | percentile 32/100 among 4,492 eligible Medicine journals32/100 |
| Uncited shareShare of window papers receiving no non-self citations in the indicator year. | 45.4%49 uncited among 108 window papers | Field median: 37.6%Medicine | percentile 61/100 among 4,521 eligible Medicine journals61/100 |
| Citation concentrationShare of non-self citations received by the journal’s most-cited 10% of window papers. | 42.6%55 of 129 non-self citations; top 11 of 108 papers | Field median: 46.3%Medicine | percentile 35/100 among 4,514 eligible Medicine journals35/100 |
Ties share a mid-rank percentile. A higher value carries no quality judgement. How field comparisons work
How this score was computed
Citations made in 2025 to articles, reviews and conference papers published in 2022–2024. Actual and Expected include only papers with a subfield.
- Actual (non-self citations)
- 129
- Expected (world-average expectation)
- 274.966009
- OJR standard error
- 0.0582
- Most-cited paper's share of citations
- 7.0%
- Citable papers in 2022–2024
- 108
- Classification coverage
- 100.0%
- Share of citable papers with a subfield
- Citations without a known source
- 1.6%
- Share of Actual from citing works without a known source
- Reference coverage in 2025
- 84.3%
- Corpus-wide share of core-journal articles and reviews with at least one matched reference
OJR = Actual ÷ Expected
129 ÷ 274.966009 ≈ 0.47
Displayed values are rounded; OJR uses the unrounded expectation.
Impact factor (2-year), 2025 = 107 ÷ 75 = 1.43
Publication window 2023–2024; includes journal self-citations.
What it publishes
In 2022–2024, the journal published 108 citable papers (articles, reviews and conference papers).
Among papers with a subfield: 31% in Infectious Diseases, 20% in Pulmonary and Respiratory Medicine, 7% in Epidemiology, 7% in Emergency Medical Services, and 5% in Applied Microbiology and Biotechnology.
Subjects follow OpenAlex’s primary-subfield classification, which may differ from a journal’s stated scope.
Among papers with a known author affiliation country: Australia (56%), United Kingdom (10%), United States (9%), Brazil (5%), and Spain (5%). Author affiliations span 33 countries in this window. A paper counts toward each country it lists, so shares can total more than 100%.
Open-access status among papers with a known status: closed (40%), hybrid (38%), bronze (11%), and green (11%).